These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

408 related items for PubMed ID: 8916595

  • 1. A comparative evaluation of pilocarpine 1% and clonidine 0.125% versus timolol 0.5%.
    Sihota R, Agarwal HC, Rajashekar YL.
    Indian J Ophthalmol; 1996 Jun; 44(2):87-9. PubMed ID: 8916595
    [Abstract] [Full Text] [Related]

  • 2. Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group.
    Bucci MG.
    J Glaucoma; 1999 Feb; 8(1):24-30. PubMed ID: 10084271
    [Abstract] [Full Text] [Related]

  • 3. The dorzolamide/timolol combination versus timolol plus pilocarpine: patient preference and impact on daily life. United States Patient Preference Study Group. International Patient Preference Study Group.
    Sverrisson T, Gross R, Pearson J, Rusk C, Adamsons I.
    J Glaucoma; 1999 Oct; 8(5):315-24. PubMed ID: 10529932
    [Abstract] [Full Text] [Related]

  • 4. The usefulness of dapiprazole, an alpha-adrenergic blocking agent, in pigmentary glaucoma.
    Mastropasqua L, Carpineto P, Ciancaglini M, Gallenga PE.
    Ophthalmic Surg Lasers; 1996 Sep; 27(9):806-9. PubMed ID: 8878205
    [Abstract] [Full Text] [Related]

  • 5. Short-term effect of apraclonidine on intraocular pressure in glaucoma patients receiving timolol and pilocarpine.
    Yüksel N, Elibol O, Caglar Y, Alçelik T.
    Ophthalmologica; 1997 Sep; 211(6):354-7. PubMed ID: 9380353
    [Abstract] [Full Text] [Related]

  • 6. Prepared association of metipranolol 0.1% + pilocarpine 2% and of timolol 0.5% + pilocarpine 2%. Comparison of clinical efficacy and topical tolerability in the treatment of patients affected by POAG tonometrically uncontrolled with beta-blocker alone (two-centre study).
    Boles Carenini B, Brogliatti B, Dorigo MT, Vadalà G, Protti R, Bellone A.
    Acta Ophthalmol Scand Suppl; 1997 Sep; (224):54-5. PubMed ID: 9589740
    [No Abstract] [Full Text] [Related]

  • 7. A prospective, long-term, randomized study of the efficacy and safety of the drug combination pilocarpine 1% with clonidine 0.06% or clonidine 0.125% versus timolol 0.25%.
    Sihota R, Rajashekhar YL, Venkatesh P, Agarwal H.
    J Ocul Pharmacol Ther; 2002 Dec; 18(6):499-506. PubMed ID: 12537676
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of two fixed beta-blocker-pilocarpine combinations. The Carteolol-Pilocarpine Study Group.
    Bron AM, Garcher CP, Sirbat D, Allaire CM, Lablache-Combier MJ, Trinquand CJ.
    Eur J Ophthalmol; 1997 Dec; 7(4):351-6. PubMed ID: 9457458
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Patient preference, efficacy, and compliance with timolol maleate ophthalmic gel-forming solution versus timolol maleate ophthalmic solution in patients with ocular hypertension or open-angle glaucoma.
    Schenker H, Maloney S, Liss C, Gormley G, Hartenbaum D.
    Clin Ther; 1999 Jan; 21(1):138-47. PubMed ID: 10090431
    [Abstract] [Full Text] [Related]

  • 16. A multicenter study comparing dorzolamide and pilocarpine as adjunctive therapy to timolol: patient preference and impact on daily life.
    Strohmaier K, Snyder E, Adamsons I.
    J Am Optom Assoc; 1998 Jul; 69(7):441-51. PubMed ID: 9697378
    [Abstract] [Full Text] [Related]

  • 17. [Efficacy and safety of timoptic depot in hypotensive therapy of glaucoma].
    Erichev VP, Iakubova LV.
    Vestn Oftalmol; 1998 Jul; 114(1):8-9. PubMed ID: 9584629
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Comparative analysis of life quality in patients receiving beta-blockers and xalathane (latanoprost)].
    Tugushi OA, Shliapuzhnikova AV, Listopadova NA.
    Vestn Oftalmol; 2005 Jul; 121(4):41-3. PubMed ID: 16223045
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.